instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'COVID-19 pneumonia'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
What was the outcome of reaction 'COVID-19'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
What was the outcome of reaction 'Hyperchromic anaemia'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,865,675 | 2021 |
What was the outcome of reaction 'Hypogammaglobulinaemia'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Not recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
What was the outcome of reaction 'Lower respiratory tract infection fungal'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
What was the outcome of reaction 'Lymphopenia'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Not recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
What was the outcome of reaction 'Respiratory distress'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,853,760 | 2021 |
What was the outcome of reaction 'Superinfection fungal'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,712,286 | 2021 |
What was the outcome of reaction 'Urinary tract infection'? | Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
Passive antibody therapy has been used to treat outbreaks of viral disease, including the ongoing pandemic of severe respiratory acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) or COVID-19. Howev... | Recovered | ReactionOutcome | CC BY | 34276706 | 19,868,066 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel ... | VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC | 34276808 | 18,573,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel ... | VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC | 34276808 | 18,573,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory symptom'. | Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel ... | VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC | 34276808 | 18,573,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin reaction'. | Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Prospectively and systematically collected real-world data on vedolizumab are scarce. We aimed to assess the long-term clinical effectiveness of vedolizumab in inflammatory bowel ... | VEDOLIZUMAB | DrugsGivenReaction | CC BY-NC | 34276808 | 18,573,659 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | FLUOROURACIL, MITOMYCIN | DrugsGivenReaction | CC BY-NC | 34276810 | 19,646,229 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | FLUOROURACIL, MITOMYCIN | DrugsGivenReaction | CC BY-NC | 34276810 | 19,646,229 | 2021 |
What was the administration route of drug 'FLUOROURACIL'? | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34276810 | 19,646,229 | 2021 |
What was the administration route of drug 'MITOMYCIN'? | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 34276810 | 19,646,229 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | CONTINUOUS INTRAVENOUS (IV) INFUSION | DrugDosageText | CC BY-NC | 34276810 | 19,646,229 | 2021 |
What was the dosage of drug 'MITOMYCIN'? | Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.
5-fluorouracil (5-FU) and mitomycin-C (MMC) with radiotherapy (RT) remain an established treatment for patients with anal cancer (AC). Genetic mutations in two major metabolizing en... | IV BOLUS DAYS?1 AND 29 | DrugDosageText | CC BY-NC | 34276810 | 19,646,229 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast discharge'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 20,608,320 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast pain'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incision site discharge'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Radiation skin injury'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 20,145,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Recall phenomenon'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 20,145,788 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Self-medication'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin induration'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin lesion'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin texture abnormal'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 20,608,320 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tissue infiltration'. | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | ACYCLOVIR, TAMOXIFEN | DrugsGivenReaction | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the administration route of drug 'ACYCLOVIR'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34277104 | 19,645,980 | 2021 |
What was the outcome of reaction 'Breast discharge'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovering | ReactionOutcome | CC BY-NC-ND | 34277104 | 20,608,320 | 2021 |
What was the outcome of reaction 'Dermatitis'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovered | ReactionOutcome | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the outcome of reaction 'Incision site discharge'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovered | ReactionOutcome | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the outcome of reaction 'Pyrexia'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovered | ReactionOutcome | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the outcome of reaction 'Recall phenomenon'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovering | ReactionOutcome | CC BY-NC-ND | 34277104 | 20,145,788 | 2021 |
What was the outcome of reaction 'Skin induration'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovered | ReactionOutcome | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the outcome of reaction 'Skin lesion'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovered | ReactionOutcome | CC BY-NC-ND | 34277104 | 19,627,396 | 2021 |
What was the outcome of reaction 'Skin texture abnormal'? | Radiodermatitis as a consequence of radiation recall induced by acyclovir: case report.
Radiation recall dermatitis (RRD) is an inflammatory reaction in an area of the skin previously irradiated for cancer treatment. The reaction usually occurs following the administration of a cytotoxic drug. Manifestations range from... | Recovering | ReactionOutcome | CC BY-NC-ND | 34277104 | 20,608,320 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chondrocalcinosis pyrophosphate'. | A Case of Pseudogout Following Zoledronic Acid Administration.
Calcium pyrophosphate dihydrate (CPPD) deposition in the joints, often referred to as pseudogout, can lead to debilitating arthritis. Rare cases of pseudogout associated with bisphosphonate therapy have been reported in the literature, although the mechanis... | ALPRAZOLAM, ESCITALOPRAM OXALATE, ESTRADIOL, FOLIC ACID, GLYCOPYRROLATE, ONDANSETRON, PANTOPRAZOLE, ROPINIROLE, TIZANIDINE, WARFARIN, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34277244 | 19,651,328 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A Case of Pseudogout Following Zoledronic Acid Administration.
Calcium pyrophosphate dihydrate (CPPD) deposition in the joints, often referred to as pseudogout, can lead to debilitating arthritis. Rare cases of pseudogout associated with bisphosphonate therapy have been reported in the literature, although the mechanis... | ALPRAZOLAM, ESCITALOPRAM OXALATE, ESTRADIOL, FOLIC ACID, GLYCOPYRROLATE, ONDANSETRON, PANTOPRAZOLE, ROPINIROLE, TIZANIDINE, WARFARIN, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34277244 | 19,651,328 | 2021-06 |
What was the administration route of drug 'ZOLEDRONIC ACID'? | A Case of Pseudogout Following Zoledronic Acid Administration.
Calcium pyrophosphate dihydrate (CPPD) deposition in the joints, often referred to as pseudogout, can lead to debilitating arthritis. Rare cases of pseudogout associated with bisphosphonate therapy have been reported in the literature, although the mechanis... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34277244 | 19,651,328 | 2021-06 |
What was the outcome of reaction 'Chondrocalcinosis pyrophosphate'? | A Case of Pseudogout Following Zoledronic Acid Administration.
Calcium pyrophosphate dihydrate (CPPD) deposition in the joints, often referred to as pseudogout, can lead to debilitating arthritis. Rare cases of pseudogout associated with bisphosphonate therapy have been reported in the literature, although the mechanis... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 34277244 | 19,651,328 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | AMANTADINE HYDROCHLORIDE, CLONAZEPAM, GABAPENTIN, HALOPERIDOL, HUMAN IMMUNOGLOBULIN G, LORAZEPAM, MEMANTINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34277291 | 19,723,693 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | AMANTADINE HYDROCHLORIDE, CLONAZEPAM, GABAPENTIN, HALOPERIDOL, HUMAN IMMUNOGLOBULIN G, LORAZEPAM, MEMANTINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34277291 | 19,723,693 | 2021-06 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34277291 | 19,723,693 | 2021-06 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34277291 | 19,723,693 | 2021-06 |
What was the dosage of drug 'LORAZEPAM'? | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | 2 MG EVERY SIX HOURS WAS COMMENCED AND TITRATED TO A HIGH DOSE | DrugDosageText | CC BY | 34277291 | 19,723,693 | 2021-06 |
What was the dosage of drug 'RITUXIMAB'? | The Effectiveness of Electroconvulsive Therapy on Catatonia in a Case of Anti-N-Methyl-D-Aspartate (Anti-NMDA) Receptor Encephalitis.
Catatonia is a symptom seen in a variety of neuropsychiatric conditions, including anti-N-Methyl D-aspartate receptor (NMDAR) encephalitis. When associated with anti-NMDAR encephalitis, ... | THIRD DOSE | DrugDosageText | CC BY | 34277291 | 19,723,693 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertriglyceridaemia'. | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | ESTRADIOL, GLIPIZIDE, METFORMIN HYDROCHLORIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34277301 | 19,649,348 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis acute'. | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | ESTRADIOL, GLIPIZIDE, METFORMIN HYDROCHLORIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the administration route of drug 'ESTRADIOL'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Oral | DrugAdministrationRoute | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the administration route of drug 'GLIPIZIDE'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Oral | DrugAdministrationRoute | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the administration route of drug 'METFORMIN HYDROCHLORIDE'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Oral | DrugAdministrationRoute | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the administration route of drug 'SPIRONOLACTONE'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Oral | DrugAdministrationRoute | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the outcome of reaction 'Hypertriglyceridaemia'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Recovering | ReactionOutcome | CC BY | 34277301 | 19,649,348 | 2021-07 |
What was the outcome of reaction 'Pancreatitis acute'? | Acute Pancreatitis in the Transgender Population.
Hypertriglyceridemia (HTG) is an uncommon but well-established etiology of acute pancreatitis (AP) leading to significant morbidity and mortality. Hormone replacement therapy in the transgender population is an underrecognized cause of elevated triglyceride (TG) levels ... | Recovering | ReactionOutcome | CC BY | 34277301 | 19,649,348 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis haemorrhagic'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diastolic dysfunction'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immunisation reaction'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE SODIUM, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,813,697 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE SODIUM, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,813,697 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomonas infection'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Staphylococcal infection'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular hypokinesia'. | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | ACYCLOVIR, CYCLOPHOSPHAMIDE, FLUCONAZOLE, FLUDARABINE PHOSPHATE, METHOTREXATE, PENTAMIDINE, RITUXIMAB, SIROLIMUS, TACROLIMUS, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the dosage of drug 'EQUINE THYMOCYTE IMMUNE GLOBULIN'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | HORSE ANTI-THYMOCYTE GLOBULIN | DrugDosageText | CC BY-NC-ND | 34277353 | 19,931,653 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | 1 DF | DrugDosageText | CC BY-NC-ND | 34277353 | 19,813,697 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
What was the outcome of reaction 'Atelectasis'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Atrial fibrillation'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Diastolic dysfunction'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Febrile neutropenia'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
What was the outcome of reaction 'Immunisation reaction'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,813,697 | 2021 |
What was the outcome of reaction 'Lactic acidosis'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Mitral valve incompetence'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Myocarditis toxoplasmal'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,910,659 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,858,701 | 2021 |
What was the outcome of reaction 'Pleural effusion'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Pseudomonas infection'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Pulmonary arterial hypertension'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Pulmonary oedema'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Renal impairment'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Staphylococcal infection'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
What was the outcome of reaction 'Toxoplasmosis'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,813,697 | 2021 |
What was the outcome of reaction 'Ventricular hypokinesia'? | Toxic 'Toxo' in the heart: Cardiac toxoplasmosis following a hematopoietic stem cell transplant- a case report.
Toxoplasmosis is a rare but potentially severe complication after allogeneic hematopoietic cell transplantation. Toxoplasma gondii-associated cardiac involvement can cause myocarditis, pericarditis, arrhythmi... | Fatal | ReactionOutcome | CC BY-NC-ND | 34277353 | 19,821,896 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cellulitis'. | Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.
Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical patho... | FAMOTIDINE, LAMOTRIGINE, LEVETIRACETAM, PREDNISOLONE, VITAMIN D NOS | DrugsGivenReaction | CC BY-NC-ND | 34277354 | 19,926,455 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Escherichia bacteraemia'. | Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.
Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical patho... | FAMOTIDINE, LAMOTRIGINE, LEVETIRACETAM, PREDNISOLONE, VITAMIN D NOS | DrugsGivenReaction | CC BY-NC-ND | 34277354 | 19,926,455 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.
Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical patho... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34277354 | 19,926,455 | 2021 |
What was the outcome of reaction 'Cellulitis'? | Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.
Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical patho... | Recovering | ReactionOutcome | CC BY-NC-ND | 34277354 | 19,926,455 | 2021 |
What was the outcome of reaction 'Escherichia bacteraemia'? | Escherichia Coli bacteremia and rapidly progressive cellulitis in a child with newly diagnosed nephrotic syndrome.
Nephrotic syndrome (NS) in children is associated with spontaneous bacterial infections, including peritonitis as well as cellulitis secondary to chronic third-spacing of intracellular fluid. Typical patho... | Recovering | ReactionOutcome | CC BY-NC-ND | 34277354 | 19,926,455 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B reactivation'. | HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies.
Hepatitis B virus reactivation (HBV-R), which can lead to HBV-related morbidity and mortality, is a common and well-known complication that occurs during the treatment of non-Hodgkin lymphoma (NHL) patients with current or past exp... | ADALIMUMAB, ETANERCEPT, GOLIMUMAB, INFLIXIMAB | DrugsGivenReaction | CC BY | 34277431 | 19,692,645 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.